Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1987 1
1991 1
1995 2
1996 4
1997 4
2000 6
2001 2
2002 2
2003 5
2004 4
2005 4
2006 3
2007 2
2008 4
2009 12
2010 3
2011 4
2012 4
2014 1
2015 3
2016 2
2017 4
2018 4
2019 2
2020 1
2021 13
2022 5
Text availability
Article attribute
Article type
Publication date

Search Results

93 results
Results by year
Filters applied: . Clear all The following term was not found in PubMed: deyrgandom
Page 1
Emerging modes-of-action in drug discovery.
Valeur E, Narjes F, Ottmann C, Plowright AT. Valeur E, et al. Medchemcomm. 2019 Jun 25;10(9):1550-1568. doi: 10.1039/c9md00263d. eCollection 2019 Sep 1. Medchemcomm. 2019. PMID: 31673315 Free PMC article. Review.
Effect of a health education program on puberty knowledge among visually impaired female adolescent students.
Bahari R, Amin Shokravi F, Anosheh M, Moridi M. Bahari R, et al. Med J Islam Repub Iran. 2021 Jun 9;35:74. doi: 10.47176/mjiri.35.74. eCollection 2021. Med J Islam Repub Iran. 2021. PMID: 34290998 Free PMC article.
Participants were recruited using convenience sampling method from Narjes educational center in Tehran. The educational needs assessments survey was used to learn about important issues and problems faced by this group to design effective educational programs. ...
Participants were recruited using convenience sampling method from Narjes educational center in Tehran. The educational needs assessm …
Inhibition of platelet aggregation as a surrogate marker.
Narjes H, Müller TH, Weisenberger H, Guth B, Brickl R. Narjes H, et al. J Clin Pharmacol. 1997 Jan;37(S1):59S-64S. doi: 10.1177/009127009703700123. J Clin Pharmacol. 1997. PMID: 9048286 Review.
Clinical pharmacokinetics of meloxicam.
Türck D, Busch U, Heinzel G, Narjes H. Türck D, et al. Arzneimittelforschung. 1997 Mar;47(3):253-8. Arzneimittelforschung. 1997. PMID: 9105543 Clinical Trial.
AZD0284, a Potent, Selective, and Orally Bioavailable Inverse Agonist of Retinoic Acid Receptor-Related Orphan Receptor C2.
Narjes F, Llinas A, von Berg S, Jirholt J, Lever S, Pehrson R, Collins M, Malmberg A, Svanberg P, Xue Y, Olsson RI, Malmberg J, Hughes G, Hossain N, Grindebacke H, Leffler A, Krutrök N, Bäck E, Ramnegård M, Lepistö M, Thunberg L, Aagaard A, McPheat J, Hansson EL, Chen R, Xiong Y, Hansson TG. Narjes F, et al. J Med Chem. 2021 Sep 23;64(18):13807-13829. doi: 10.1021/acs.jmedchem.1c01197. Epub 2021 Aug 31. J Med Chem. 2021. PMID: 34464130
93 results